Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphangioleiomyomatosis | 12 | 2023 | 23 | 3.560 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 10 | 2023 | 20 | 3.010 |
Why?
|
Acute Lung Injury | 11 | 2022 | 313 | 2.730 |
Why?
|
Neutrophils | 26 | 2020 | 1246 | 2.550 |
Why?
|
Lung | 31 | 2023 | 3830 | 2.370 |
Why?
|
Pulmonary Fibrosis | 6 | 2022 | 305 | 2.360 |
Why?
|
Transforming Growth Factor beta | 7 | 2022 | 468 | 1.920 |
Why?
|
Matrix Metalloproteinase 3 | 11 | 2022 | 22 | 1.890 |
Why?
|
Fibroblasts | 18 | 2023 | 846 | 1.850 |
Why?
|
Protein Tyrosine Phosphatases | 10 | 2023 | 162 | 1.840 |
Why?
|
Signal Transduction | 34 | 2020 | 4902 | 1.770 |
Why?
|
Protein-Tyrosine Kinases | 6 | 2018 | 442 | 1.750 |
Why?
|
Focal Adhesions | 14 | 2018 | 44 | 1.490 |
Why?
|
Leukocyte Elastase | 7 | 2013 | 84 | 1.340 |
Why?
|
Lung Diseases | 4 | 2023 | 764 | 1.320 |
Why?
|
Thorax | 3 | 2022 | 49 | 1.310 |
Why?
|
Histiocytosis, Langerhans-Cell | 2 | 2023 | 36 | 1.260 |
Why?
|
Interleukin-1 | 15 | 2020 | 987 | 1.260 |
Why?
|
Respiration Disorders | 2 | 2018 | 67 | 1.110 |
Why?
|
Epithelial Cells | 11 | 2021 | 995 | 1.090 |
Why?
|
Idiopathic Pulmonary Fibrosis | 4 | 2022 | 456 | 1.060 |
Why?
|
Phagocytosis | 11 | 2011 | 368 | 0.970 |
Why?
|
Receptor, PAR-1 | 3 | 2009 | 22 | 0.960 |
Why?
|
Birt-Hogg-Dube Syndrome | 1 | 2023 | 6 | 0.930 |
Why?
|
Animals | 73 | 2023 | 34133 | 0.910 |
Why?
|
Respiratory Mucosa | 6 | 2013 | 263 | 0.890 |
Why?
|
Particulate Matter | 6 | 2022 | 257 | 0.880 |
Why?
|
Cysts | 1 | 2023 | 94 | 0.860 |
Why?
|
Transendothelial and Transepithelial Migration | 2 | 2013 | 29 | 0.850 |
Why?
|
Apoptosis | 10 | 2010 | 2532 | 0.850 |
Why?
|
beta Catenin | 3 | 2013 | 223 | 0.830 |
Why?
|
Congresses as Topic | 1 | 2023 | 208 | 0.820 |
Why?
|
Mice | 46 | 2023 | 15888 | 0.810 |
Why?
|
Cells, Cultured | 26 | 2020 | 4162 | 0.790 |
Why?
|
Pneumonia | 8 | 2018 | 605 | 0.760 |
Why?
|
Societies, Medical | 3 | 2023 | 741 | 0.730 |
Why?
|
Respiratory Tract Diseases | 3 | 2022 | 140 | 0.720 |
Why?
|
rac1 GTP-Binding Protein | 6 | 2012 | 58 | 0.710 |
Why?
|
Humans | 107 | 2023 | 122796 | 0.690 |
Why?
|
Bleomycin | 6 | 2022 | 217 | 0.690 |
Why?
|
Macrophages | 8 | 2020 | 1334 | 0.680 |
Why?
|
Proto-Oncogene Proteins | 5 | 2013 | 646 | 0.660 |
Why?
|
Phosphorylation | 13 | 2020 | 1733 | 0.630 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 5 | 2019 | 302 | 0.620 |
Why?
|
Bronchitis | 2 | 2019 | 46 | 0.620 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 833 | 0.580 |
Why?
|
Hyaluronan Receptors | 2 | 2007 | 96 | 0.580 |
Why?
|
Cell Adhesion Molecules | 2 | 2016 | 188 | 0.560 |
Why?
|
Pulmonary Medicine | 3 | 2013 | 91 | 0.560 |
Why?
|
Lung Transplantation | 5 | 2006 | 273 | 0.550 |
Why?
|
Health | 1 | 2016 | 81 | 0.550 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 8 | 2020 | 167 | 0.540 |
Why?
|
Respiratory System | 1 | 2016 | 144 | 0.520 |
Why?
|
Delivery of Health Care | 1 | 2022 | 915 | 0.520 |
Why?
|
Bronchoscopy | 1 | 2016 | 254 | 0.510 |
Why?
|
Reactive Oxygen Species | 4 | 2006 | 592 | 0.500 |
Why?
|
Immunity, Innate | 4 | 2011 | 762 | 0.490 |
Why?
|
Lung Neoplasms | 5 | 2019 | 2216 | 0.480 |
Why?
|
Matrix Metalloproteinases | 1 | 2014 | 91 | 0.480 |
Why?
|
Cell Communication | 3 | 2013 | 287 | 0.470 |
Why?
|
Respiratory Tract Infections | 4 | 2014 | 335 | 0.470 |
Why?
|
Mice, Inbred C57BL | 14 | 2021 | 5020 | 0.460 |
Why?
|
CCN Intercellular Signaling Proteins | 1 | 2013 | 5 | 0.460 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2013 | 5 | 0.460 |
Why?
|
Phagosomes | 4 | 2010 | 44 | 0.450 |
Why?
|
Calpain | 1 | 2013 | 55 | 0.450 |
Why?
|
Disease Models, Animal | 8 | 2022 | 3799 | 0.440 |
Why?
|
Atherosclerosis | 1 | 2016 | 354 | 0.420 |
Why?
|
Biomarkers | 5 | 2021 | 3662 | 0.420 |
Why?
|
Intracellular Signaling Peptides and Proteins | 6 | 2006 | 432 | 0.420 |
Why?
|
Bacterial Infections | 3 | 2014 | 234 | 0.420 |
Why?
|
Epithelium | 2 | 2011 | 309 | 0.410 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 361 | 0.410 |
Why?
|
Sepsis | 3 | 2006 | 546 | 0.410 |
Why?
|
Extracellular Matrix | 2 | 2015 | 461 | 0.400 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 5 | 2018 | 8 | 0.400 |
Why?
|
Endothelium | 1 | 2011 | 121 | 0.390 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 2 | 2022 | 25 | 0.390 |
Why?
|
Sirolimus | 4 | 2019 | 198 | 0.390 |
Why?
|
Cystic Fibrosis | 7 | 2019 | 1003 | 0.380 |
Why?
|
Tomography, X-Ray Computed | 6 | 2023 | 2500 | 0.370 |
Why?
|
Enzyme Inhibitors | 3 | 2011 | 836 | 0.370 |
Why?
|
Neutrophil Activation | 3 | 2007 | 100 | 0.360 |
Why?
|
src-Family Kinases | 3 | 2022 | 109 | 0.350 |
Why?
|
Cell Adhesion | 8 | 2013 | 454 | 0.350 |
Why?
|
Indoles | 1 | 2011 | 318 | 0.350 |
Why?
|
Molecular Probe Techniques | 1 | 2009 | 9 | 0.340 |
Why?
|
Inflammation | 11 | 2022 | 2598 | 0.340 |
Why?
|
Pulmonary Alveolar Proteinosis | 1 | 2008 | 17 | 0.330 |
Why?
|
Pseudomonas aeruginosa | 2 | 2007 | 310 | 0.320 |
Why?
|
Receptor, PAR-2 | 1 | 2007 | 9 | 0.320 |
Why?
|
Monocytes | 3 | 2021 | 523 | 0.320 |
Why?
|
Caveolin 1 | 1 | 2007 | 23 | 0.320 |
Why?
|
Actins | 7 | 2023 | 409 | 0.310 |
Why?
|
Macrophage-1 Antigen | 1 | 2007 | 36 | 0.310 |
Why?
|
Transfection | 7 | 2009 | 909 | 0.310 |
Why?
|
Critical Care | 3 | 2017 | 563 | 0.310 |
Why?
|
Cell Movement | 3 | 2013 | 929 | 0.300 |
Why?
|
Enzyme Activation | 8 | 2020 | 864 | 0.300 |
Why?
|
Calcium Signaling | 6 | 2015 | 232 | 0.300 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2022 | 466 | 0.300 |
Why?
|
Endoplasmic Reticulum | 6 | 2015 | 250 | 0.300 |
Why?
|
Dyspnea | 2 | 2019 | 214 | 0.300 |
Why?
|
Fluorescent Dyes | 1 | 2009 | 319 | 0.290 |
Why?
|
Stroke | 1 | 2016 | 1090 | 0.290 |
Why?
|
Reactive Nitrogen Species | 1 | 2006 | 27 | 0.290 |
Why?
|
Cytoplasmic Granules | 2 | 2010 | 100 | 0.290 |
Why?
|
RNA, Small Interfering | 7 | 2018 | 581 | 0.280 |
Why?
|
Pseudomonas Infections | 1 | 2007 | 198 | 0.280 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2019 | 115 | 0.280 |
Why?
|
Endothelial Cells | 1 | 2011 | 749 | 0.280 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 6 | 2010 | 31 | 0.270 |
Why?
|
Peptide Hydrolases | 2 | 2022 | 109 | 0.270 |
Why?
|
Platelet Activation | 1 | 2005 | 71 | 0.270 |
Why?
|
Lipid Metabolism | 1 | 2009 | 482 | 0.270 |
Why?
|
rac GTP-Binding Proteins | 4 | 2012 | 37 | 0.270 |
Why?
|
Radiography, Thoracic | 1 | 2006 | 168 | 0.260 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 2 | 2015 | 27 | 0.260 |
Why?
|
Mice, Knockout | 11 | 2018 | 2737 | 0.260 |
Why?
|
NF-kappa B | 1 | 2009 | 676 | 0.260 |
Why?
|
Embryonic Development | 1 | 2005 | 120 | 0.260 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2004 | 358 | 0.260 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2003 | 306 | 0.260 |
Why?
|
Permeability | 4 | 2012 | 155 | 0.250 |
Why?
|
Protein Binding | 12 | 2021 | 2010 | 0.250 |
Why?
|
Lung Injury | 3 | 2015 | 215 | 0.250 |
Why?
|
Gene Deletion | 4 | 2014 | 365 | 0.250 |
Why?
|
Hypertension, Pulmonary | 1 | 2016 | 1900 | 0.240 |
Why?
|
Collagen | 3 | 2020 | 436 | 0.240 |
Why?
|
Breath Tests | 1 | 2004 | 87 | 0.240 |
Why?
|
Spike Glycoprotein, Coronavirus | 2 | 2022 | 98 | 0.240 |
Why?
|
Afghanistan | 5 | 2022 | 126 | 0.240 |
Why?
|
Supreme Court Decisions | 1 | 2023 | 10 | 0.230 |
Why?
|
Disease Progression | 5 | 2019 | 2546 | 0.230 |
Why?
|
NIH 3T3 Cells | 5 | 2014 | 141 | 0.230 |
Why?
|
Mitochondria, Muscle | 1 | 2004 | 98 | 0.230 |
Why?
|
Employment | 1 | 2004 | 142 | 0.220 |
Why?
|
Antibodies, Monoclonal, Humanized | 3 | 2022 | 658 | 0.220 |
Why?
|
Mastication | 1 | 2022 | 14 | 0.220 |
Why?
|
Arthritis | 1 | 2023 | 115 | 0.210 |
Why?
|
Female | 28 | 2020 | 63629 | 0.210 |
Why?
|
Cytokines | 7 | 2018 | 1928 | 0.210 |
Why?
|
Fibrosis | 2 | 2022 | 497 | 0.210 |
Why?
|
Lymphocyte Activation | 2 | 2005 | 1148 | 0.210 |
Why?
|
MAP Kinase Signaling System | 3 | 2018 | 304 | 0.210 |
Why?
|
Adenoviridae | 2 | 2014 | 195 | 0.210 |
Why?
|
Sputum | 1 | 2004 | 293 | 0.210 |
Why?
|
Rare Diseases | 1 | 2002 | 116 | 0.210 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2022 | 92 | 0.200 |
Why?
|
Alveolar Epithelial Cells | 1 | 2022 | 98 | 0.200 |
Why?
|
Cell Line | 6 | 2020 | 2785 | 0.200 |
Why?
|
Tyrosine | 2 | 2017 | 267 | 0.200 |
Why?
|
Burkholderia cenocepacia | 2 | 2011 | 4 | 0.200 |
Why?
|
Monitoring, Physiologic | 1 | 2004 | 288 | 0.200 |
Why?
|
Mutation | 6 | 2022 | 3493 | 0.200 |
Why?
|
Research Report | 1 | 2022 | 83 | 0.200 |
Why?
|
Animal Care Committees | 1 | 2021 | 6 | 0.200 |
Why?
|
Animals, Laboratory | 1 | 2021 | 13 | 0.200 |
Why?
|
Animal Welfare | 1 | 2021 | 14 | 0.200 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 22 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2009 | 433 | 0.190 |
Why?
|
Interleukin-1 Receptor-Like 1 Protein | 1 | 2020 | 24 | 0.190 |
Why?
|
Interleukin-33 | 1 | 2020 | 39 | 0.190 |
Why?
|
Gingiva | 4 | 2013 | 22 | 0.190 |
Why?
|
Cadherins | 2 | 2011 | 190 | 0.180 |
Why?
|
Interleukin-8 | 3 | 2018 | 256 | 0.180 |
Why?
|
Diagnosis, Differential | 2 | 2023 | 1423 | 0.180 |
Why?
|
Leucine | 1 | 2020 | 117 | 0.180 |
Why?
|
Proteolysis | 1 | 2020 | 149 | 0.180 |
Why?
|
Matrix Metalloproteinase Inhibitors | 1 | 2019 | 11 | 0.180 |
Why?
|
Lymphocytes | 3 | 2006 | 360 | 0.180 |
Why?
|
Immunoblotting | 4 | 2011 | 318 | 0.180 |
Why?
|
Inositol 1,4,5-Trisphosphate Receptors | 3 | 2015 | 28 | 0.180 |
Why?
|
Microfilament Proteins | 1 | 2020 | 135 | 0.180 |
Why?
|
Blood Transfusion | 1 | 2002 | 312 | 0.170 |
Why?
|
Intestinal Mucosa | 1 | 2004 | 543 | 0.170 |
Why?
|
Directed Molecular Evolution | 1 | 2019 | 25 | 0.170 |
Why?
|
Rats | 9 | 2011 | 5426 | 0.170 |
Why?
|
Aerosols | 1 | 2020 | 224 | 0.170 |
Why?
|
Inflammasomes | 2 | 2018 | 123 | 0.170 |
Why?
|
Fibronectins | 2 | 2012 | 115 | 0.170 |
Why?
|
Male | 23 | 2020 | 59639 | 0.170 |
Why?
|
Retinal Degeneration | 1 | 2018 | 28 | 0.170 |
Why?
|
Adult | 19 | 2020 | 32385 | 0.160 |
Why?
|
Middle Aged | 17 | 2020 | 28563 | 0.160 |
Why?
|
Iraq War, 2003-2011 | 1 | 2019 | 172 | 0.160 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2011 | 294 | 0.160 |
Why?
|
Consensus | 1 | 2021 | 554 | 0.160 |
Why?
|
Actin Capping Proteins | 1 | 2018 | 1 | 0.160 |
Why?
|
Afghan Campaign 2001- | 1 | 2019 | 190 | 0.160 |
Why?
|
Interleukin-13 | 1 | 2018 | 138 | 0.160 |
Why?
|
Pleural Diseases | 1 | 2017 | 22 | 0.160 |
Why?
|
Allergens | 1 | 2021 | 421 | 0.160 |
Why?
|
Vascular Endothelial Growth Factor D | 2 | 2016 | 9 | 0.160 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2014 | 408 | 0.160 |
Why?
|
Intensive Care Units | 1 | 2002 | 664 | 0.160 |
Why?
|
Calcium | 5 | 2014 | 1244 | 0.150 |
Why?
|
Ischemic Preconditioning | 2 | 2010 | 29 | 0.150 |
Why?
|
Actinin | 2 | 2008 | 14 | 0.150 |
Why?
|
Bronchoalveolar Lavage Fluid | 5 | 2021 | 633 | 0.150 |
Why?
|
Defensins | 2 | 2008 | 3 | 0.150 |
Why?
|
Paxillin | 2 | 2008 | 10 | 0.150 |
Why?
|
Oxidative Stress | 1 | 2003 | 1204 | 0.150 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2014 | 1181 | 0.140 |
Why?
|
Tuberous Sclerosis | 2 | 2006 | 38 | 0.140 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 1003 | 0.140 |
Why?
|
Mitochondria | 3 | 2009 | 809 | 0.140 |
Why?
|
Intraocular Pressure | 1 | 2018 | 286 | 0.140 |
Why?
|
Microbial Viability | 2 | 2007 | 82 | 0.140 |
Why?
|
Caspase 3 | 2 | 2009 | 246 | 0.140 |
Why?
|
Genetic Vectors | 2 | 2011 | 310 | 0.140 |
Why?
|
Liposomes | 3 | 2009 | 158 | 0.140 |
Why?
|
Models, Biological | 5 | 2020 | 1756 | 0.140 |
Why?
|
Glaucoma | 1 | 2018 | 214 | 0.130 |
Why?
|
Secretory Vesicles | 2 | 2005 | 26 | 0.130 |
Why?
|
Ligands | 3 | 2022 | 582 | 0.130 |
Why?
|
Military Personnel | 2 | 2021 | 584 | 0.130 |
Why?
|
CD11b Antigen | 4 | 2010 | 59 | 0.130 |
Why?
|
RNA, Messenger | 6 | 2022 | 2720 | 0.130 |
Why?
|
Influenza, Human | 1 | 2021 | 566 | 0.130 |
Why?
|
Inflammation Mediators | 3 | 2009 | 515 | 0.130 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 3 | 2020 | 21 | 0.130 |
Why?
|
Phospholipase C gamma | 2 | 2013 | 28 | 0.130 |
Why?
|
Catalytic Domain | 2 | 2019 | 210 | 0.130 |
Why?
|
Antiviral Agents | 1 | 2021 | 670 | 0.130 |
Why?
|
Genes, Reporter | 2 | 2014 | 274 | 0.130 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2014 | 131 | 0.130 |
Why?
|
Attitude of Health Personnel | 1 | 2002 | 1012 | 0.130 |
Why?
|
Receptors, CXCR4 | 2 | 2006 | 85 | 0.130 |
Why?
|
Gene Expression Regulation | 4 | 2020 | 2491 | 0.130 |
Why?
|
Severity of Illness Index | 4 | 2018 | 2784 | 0.130 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2014 | 196 | 0.120 |
Why?
|
Biomedical Research | 1 | 2020 | 630 | 0.120 |
Why?
|
Tumor Suppressor Proteins | 2 | 2006 | 299 | 0.120 |
Why?
|
Smad Proteins | 1 | 2014 | 38 | 0.120 |
Why?
|
Transcription Factors | 1 | 2022 | 1616 | 0.120 |
Why?
|
Chemotaxis, Leukocyte | 5 | 2006 | 135 | 0.120 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2014 | 54 | 0.120 |
Why?
|
Respiratory Function Tests | 2 | 2006 | 563 | 0.120 |
Why?
|
Mice, Transgenic | 4 | 2014 | 2079 | 0.120 |
Why?
|
Toll-Like Receptors | 1 | 2014 | 169 | 0.120 |
Why?
|
Asthma | 3 | 2019 | 2130 | 0.120 |
Why?
|
Connective Tissue | 1 | 2013 | 38 | 0.120 |
Why?
|
Transplantation, Heterologous | 2 | 2005 | 194 | 0.120 |
Why?
|
United States | 5 | 2023 | 13272 | 0.120 |
Why?
|
Caspases | 2 | 2005 | 275 | 0.120 |
Why?
|
ras-GRF1 | 1 | 2013 | 2 | 0.120 |
Why?
|
ras Guanine Nucleotide Exchange Factors | 1 | 2013 | 8 | 0.120 |
Why?
|
Interleukin-1beta | 2 | 2013 | 383 | 0.120 |
Why?
|
Periodontitis | 1 | 2013 | 42 | 0.110 |
Why?
|
Eosinophils | 2 | 2008 | 273 | 0.110 |
Why?
|
E1A-Associated p300 Protein | 1 | 2013 | 9 | 0.110 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2012 | 182 | 0.110 |
Why?
|
Gap Junctions | 1 | 2013 | 59 | 0.110 |
Why?
|
Gene Expression | 4 | 2013 | 1506 | 0.110 |
Why?
|
Cell-Derived Microparticles | 1 | 2013 | 62 | 0.110 |
Why?
|
Homeostasis | 1 | 2016 | 596 | 0.110 |
Why?
|
Coculture Techniques | 1 | 2013 | 213 | 0.110 |
Why?
|
Neuropeptides | 1 | 2012 | 70 | 0.110 |
Why?
|
Aged | 9 | 2019 | 20495 | 0.110 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2011 | 25 | 0.100 |
Why?
|
Protein Transport | 2 | 2011 | 418 | 0.100 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2011 | 57 | 0.100 |
Why?
|
Anti-Inflammatory Agents | 2 | 2006 | 469 | 0.100 |
Why?
|
Cyclin D1 | 1 | 2011 | 63 | 0.100 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2011 | 783 | 0.100 |
Why?
|
Prognosis | 3 | 2009 | 3563 | 0.100 |
Why?
|
Burkholderia Infections | 1 | 2010 | 5 | 0.100 |
Why?
|
Actin Cytoskeleton | 1 | 2011 | 103 | 0.100 |
Why?
|
Macrophages, Alveolar | 1 | 2014 | 364 | 0.100 |
Why?
|
Rats, Wistar | 2 | 2009 | 405 | 0.090 |
Why?
|
ras Proteins | 1 | 2011 | 142 | 0.090 |
Why?
|
Transgenes | 2 | 2008 | 179 | 0.090 |
Why?
|
Receptors, IgG | 5 | 2009 | 100 | 0.090 |
Why?
|
Histological Techniques | 1 | 2010 | 45 | 0.090 |
Why?
|
rab GTP-Binding Proteins | 1 | 2010 | 64 | 0.090 |
Why?
|
Flow Cytometry | 4 | 2006 | 1128 | 0.090 |
Why?
|
Membrane Potentials | 2 | 2008 | 273 | 0.090 |
Why?
|
Antibodies, Neutralizing | 2 | 2022 | 229 | 0.090 |
Why?
|
Microscopy, Confocal | 2 | 2009 | 319 | 0.090 |
Why?
|
Survivors | 1 | 2013 | 440 | 0.090 |
Why?
|
Cell Culture Techniques | 2 | 2009 | 354 | 0.090 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 1519 | 0.090 |
Why?
|
alpha-Defensins | 1 | 2009 | 11 | 0.090 |
Why?
|
Exocytosis | 2 | 2010 | 90 | 0.090 |
Why?
|
RNA Interference | 1 | 2011 | 473 | 0.090 |
Why?
|
Antibodies, Antinuclear | 1 | 2009 | 59 | 0.090 |
Why?
|
Pneumothorax | 2 | 2006 | 49 | 0.090 |
Why?
|
Amino Acyl-tRNA Synthetases | 1 | 2009 | 25 | 0.090 |
Why?
|
bcl-2-Associated X Protein | 1 | 2009 | 47 | 0.090 |
Why?
|
Blotting, Western | 2 | 2009 | 1225 | 0.090 |
Why?
|
Ion Transport | 1 | 2009 | 62 | 0.090 |
Why?
|
Chloride Channels | 1 | 2009 | 35 | 0.090 |
Why?
|
Idiopathic Interstitial Pneumonias | 1 | 2009 | 42 | 0.090 |
Why?
|
Membrane Fusion | 2 | 2010 | 40 | 0.090 |
Why?
|
Forced Expiratory Volume | 3 | 2019 | 562 | 0.090 |
Why?
|
Connective Tissue Diseases | 1 | 2009 | 58 | 0.080 |
Why?
|
ErbB Receptors | 1 | 2012 | 571 | 0.080 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2009 | 115 | 0.080 |
Why?
|
Electric Impedance | 1 | 2009 | 101 | 0.080 |
Why?
|
Retroviridae | 1 | 2008 | 91 | 0.080 |
Why?
|
Protein Domains | 2 | 2020 | 219 | 0.080 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 336 | 0.080 |
Why?
|
Biological Assay | 1 | 2009 | 123 | 0.080 |
Why?
|
Egtazic Acid | 2 | 2005 | 45 | 0.080 |
Why?
|
Cell Polarity | 1 | 2009 | 130 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2009 | 198 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2011 | 377 | 0.080 |
Why?
|
Caveolae | 1 | 2007 | 16 | 0.080 |
Why?
|
Antigens, CD | 3 | 2010 | 506 | 0.080 |
Why?
|
Bronchiectasis | 1 | 2009 | 102 | 0.080 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 1 | 2007 | 68 | 0.080 |
Why?
|
rap1 GTP-Binding Proteins | 1 | 2007 | 5 | 0.080 |
Why?
|
Fluorescent Antibody Technique | 1 | 2009 | 420 | 0.080 |
Why?
|
Cell Membrane | 3 | 2012 | 741 | 0.080 |
Why?
|
CD18 Antigens | 1 | 2007 | 37 | 0.080 |
Why?
|
Dendritic Cells | 2 | 2008 | 445 | 0.080 |
Why?
|
Blood Platelets | 2 | 2013 | 369 | 0.080 |
Why?
|
Transcription, Genetic | 1 | 2014 | 1355 | 0.080 |
Why?
|
Cell Line, Tumor | 2 | 2012 | 2904 | 0.080 |
Why?
|
Glomerulonephritis | 1 | 2008 | 61 | 0.080 |
Why?
|
Bone Marrow | 1 | 2008 | 257 | 0.080 |
Why?
|
Mast Cells | 1 | 2008 | 121 | 0.070 |
Why?
|
Fibrinogen | 1 | 2008 | 162 | 0.070 |
Why?
|
Bronchi | 2 | 2005 | 253 | 0.070 |
Why?
|
Murine hepatitis virus | 1 | 2006 | 16 | 0.070 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2006 | 14 | 0.070 |
Why?
|
Aerospace Medicine | 1 | 2006 | 23 | 0.070 |
Why?
|
Aircraft | 1 | 2006 | 29 | 0.070 |
Why?
|
Binding Sites | 2 | 2021 | 1247 | 0.070 |
Why?
|
Chemokines | 1 | 2008 | 233 | 0.070 |
Why?
|
Vanadates | 1 | 2006 | 30 | 0.070 |
Why?
|
Microscopy, Fluorescence | 3 | 2004 | 418 | 0.070 |
Why?
|
Syk Kinase | 1 | 2006 | 29 | 0.070 |
Why?
|
Regenerative Medicine | 1 | 2006 | 46 | 0.070 |
Why?
|
Subcellular Fractions | 2 | 2006 | 86 | 0.070 |
Why?
|
Diuretics | 1 | 2006 | 78 | 0.070 |
Why?
|
Oligopeptides | 2 | 2005 | 255 | 0.070 |
Why?
|
Receptors, Purinergic P2 | 1 | 2005 | 21 | 0.070 |
Why?
|
Respiratory Burst | 1 | 2005 | 33 | 0.070 |
Why?
|
Pancreatic Elastase | 1 | 2006 | 74 | 0.070 |
Why?
|
Cell Survival | 2 | 2006 | 1075 | 0.070 |
Why?
|
Cerebral Infarction | 1 | 2005 | 45 | 0.070 |
Why?
|
Rats, Sprague-Dawley | 1 | 2011 | 2501 | 0.070 |
Why?
|
Spirometry | 1 | 2006 | 291 | 0.070 |
Why?
|
Travel | 1 | 2006 | 124 | 0.070 |
Why?
|
Bone Development | 1 | 2005 | 55 | 0.070 |
Why?
|
Drug Design | 1 | 2006 | 163 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2012 | 837 | 0.070 |
Why?
|
Osmolar Concentration | 1 | 2005 | 185 | 0.070 |
Why?
|
Endothelium, Vascular | 3 | 2013 | 923 | 0.070 |
Why?
|
Amino Acid Sequence | 2 | 2020 | 2123 | 0.070 |
Why?
|
Caspase 9 | 1 | 2005 | 52 | 0.070 |
Why?
|
Immunity | 1 | 2006 | 130 | 0.070 |
Why?
|
Cytosol | 2 | 2004 | 229 | 0.060 |
Why?
|
Neural Tube Defects | 1 | 2005 | 64 | 0.060 |
Why?
|
Structure-Activity Relationship | 2 | 2020 | 536 | 0.060 |
Why?
|
Drosophila melanogaster | 1 | 2006 | 202 | 0.060 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 156 | 0.060 |
Why?
|
Cyclic AMP | 1 | 2005 | 260 | 0.060 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2008 | 367 | 0.060 |
Why?
|
Quality of Life | 2 | 2013 | 2457 | 0.060 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2006 | 244 | 0.060 |
Why?
|
Type C Phospholipases | 1 | 2004 | 76 | 0.060 |
Why?
|
Developing Countries | 1 | 2006 | 273 | 0.060 |
Why?
|
Platelet Activating Factor | 1 | 2004 | 95 | 0.060 |
Why?
|
Glycogen Synthase Kinase 3 beta | 1 | 2004 | 62 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 1625 | 0.060 |
Why?
|
Escherichia coli | 2 | 2005 | 767 | 0.060 |
Why?
|
Time Factors | 5 | 2014 | 6682 | 0.060 |
Why?
|
Phospholipases A | 1 | 2004 | 102 | 0.060 |
Why?
|
Gene Knockdown Techniques | 2 | 2018 | 322 | 0.060 |
Why?
|
Autoimmune Diseases | 1 | 2008 | 408 | 0.060 |
Why?
|
NADPH Oxidases | 1 | 2004 | 141 | 0.060 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2004 | 83 | 0.060 |
Why?
|
Neovascularization, Physiologic | 1 | 2005 | 192 | 0.060 |
Why?
|
Vas Deferens | 1 | 2003 | 17 | 0.060 |
Why?
|
Leukotriene Antagonists | 1 | 2004 | 40 | 0.060 |
Why?
|
Chemotaxis | 1 | 2004 | 141 | 0.060 |
Why?
|
Muscle, Smooth | 1 | 2004 | 159 | 0.060 |
Why?
|
Survival Rate | 2 | 2011 | 1810 | 0.060 |
Why?
|
Clinical Laboratory Techniques | 1 | 2004 | 93 | 0.060 |
Why?
|
L-Selectin | 1 | 2003 | 27 | 0.060 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2023 | 72 | 0.060 |
Why?
|
Vitamin E | 1 | 2003 | 119 | 0.060 |
Why?
|
Biopsy | 2 | 2017 | 1090 | 0.060 |
Why?
|
Metalloendopeptidases | 1 | 2003 | 57 | 0.060 |
Why?
|
Chromans | 1 | 2003 | 21 | 0.060 |
Why?
|
3T3 Cells | 1 | 2003 | 141 | 0.060 |
Why?
|
Adrenergic beta-Agonists | 1 | 2004 | 134 | 0.060 |
Why?
|
Lung Compliance | 2 | 2014 | 50 | 0.060 |
Why?
|
Transposases | 1 | 2022 | 10 | 0.060 |
Why?
|
Oxidation-Reduction | 1 | 2006 | 931 | 0.060 |
Why?
|
Sampling Studies | 1 | 2002 | 95 | 0.060 |
Why?
|
Electrocardiography | 1 | 2006 | 620 | 0.050 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2003 | 91 | 0.050 |
Why?
|
Hematopoietic Stem Cells | 1 | 2005 | 370 | 0.050 |
Why?
|
Cohort Studies | 2 | 2019 | 5294 | 0.050 |
Why?
|
Matrix Metalloproteinase 10 | 1 | 2022 | 3 | 0.050 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2006 | 401 | 0.050 |
Why?
|
Perception | 1 | 2005 | 324 | 0.050 |
Why?
|
Hemagglutinins | 1 | 2001 | 11 | 0.050 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 130 | 0.050 |
Why?
|
U937 Cells | 1 | 2001 | 30 | 0.050 |
Why?
|
HL-60 Cells | 1 | 2001 | 30 | 0.050 |
Why?
|
Risk Assessment | 2 | 2020 | 3213 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2001 | 99 | 0.050 |
Why?
|
Staphylococcus aureus | 1 | 2005 | 400 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 302 | 0.050 |
Why?
|
Educational Status | 1 | 2004 | 448 | 0.050 |
Why?
|
Cluster Analysis | 1 | 2023 | 493 | 0.050 |
Why?
|
Phosphatidylinositol Phosphates | 1 | 2001 | 47 | 0.050 |
Why?
|
Immunity, Humoral | 1 | 2022 | 116 | 0.050 |
Why?
|
Glutathione Transferase | 1 | 2001 | 98 | 0.050 |
Why?
|
Kinetics | 2 | 2021 | 1658 | 0.050 |
Why?
|
Vital Capacity | 2 | 2013 | 277 | 0.050 |
Why?
|
Canada | 1 | 2002 | 355 | 0.050 |
Why?
|
Iraq | 1 | 2021 | 95 | 0.050 |
Why?
|
Antigen-Antibody Reactions | 1 | 2021 | 54 | 0.050 |
Why?
|
Age Factors | 2 | 2011 | 3114 | 0.050 |
Why?
|
Comorbidity | 1 | 2006 | 1600 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2005 | 715 | 0.050 |
Why?
|
Bronchoalveolar Lavage | 1 | 2021 | 98 | 0.050 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2021 | 59 | 0.050 |
Why?
|
Graft Rejection | 1 | 2005 | 556 | 0.050 |
Why?
|
Hemorrhage | 1 | 2005 | 663 | 0.050 |
Why?
|
Surveys and Questionnaires | 2 | 2004 | 4882 | 0.050 |
Why?
|
Attitude to Health | 1 | 2005 | 417 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2006 | 349 | 0.050 |
Why?
|
Veterinarians | 1 | 2021 | 11 | 0.050 |
Why?
|
Protein Engineering | 1 | 2022 | 106 | 0.050 |
Why?
|
Surface Plasmon Resonance | 1 | 2021 | 85 | 0.050 |
Why?
|
Cytoplasm | 1 | 2001 | 276 | 0.050 |
Why?
|
Receptors, Virus | 1 | 2021 | 78 | 0.050 |
Why?
|
Repetitive Sequences, Amino Acid | 1 | 2020 | 16 | 0.050 |
Why?
|
Waiting Lists | 1 | 2002 | 229 | 0.050 |
Why?
|
Molecular Docking Simulation | 1 | 2021 | 102 | 0.050 |
Why?
|
Receptors, Interleukin-1 Type I | 1 | 2020 | 22 | 0.050 |
Why?
|
Cell-Penetrating Peptides | 1 | 2020 | 18 | 0.050 |
Why?
|
Anti-Asthmatic Agents | 1 | 2004 | 326 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2005 | 543 | 0.050 |
Why?
|
Communicable Disease Control | 1 | 2020 | 74 | 0.050 |
Why?
|
Down-Regulation | 2 | 2018 | 654 | 0.050 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2021 | 141 | 0.050 |
Why?
|
Middle East | 1 | 2019 | 11 | 0.050 |
Why?
|
Up-Regulation | 2 | 2018 | 891 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2019 | 6845 | 0.040 |
Why?
|
Motivation | 1 | 2004 | 515 | 0.040 |
Why?
|
Oxygen Consumption | 1 | 2002 | 613 | 0.040 |
Why?
|
Two-Hybrid System Techniques | 1 | 2019 | 58 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2004 | 2977 | 0.040 |
Why?
|
Particle Size | 1 | 2020 | 344 | 0.040 |
Why?
|
Adaptation, Physiological | 1 | 2003 | 510 | 0.040 |
Why?
|
Prospective Studies | 2 | 2013 | 6704 | 0.040 |
Why?
|
Models, Animal | 1 | 2021 | 373 | 0.040 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 420 | 0.040 |
Why?
|
Amino Acids | 1 | 2022 | 463 | 0.040 |
Why?
|
Bronchial Diseases | 1 | 2018 | 35 | 0.040 |
Why?
|
Antioxidants | 1 | 2003 | 581 | 0.040 |
Why?
|
Cough | 1 | 2019 | 104 | 0.040 |
Why?
|
Gliosis | 1 | 2018 | 35 | 0.040 |
Why?
|
Premenopause | 1 | 2019 | 109 | 0.040 |
Why?
|
Health Status | 1 | 2004 | 758 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 1 | 2001 | 661 | 0.040 |
Why?
|
Chromatin | 1 | 2022 | 450 | 0.040 |
Why?
|
Confidence Intervals | 1 | 2019 | 339 | 0.040 |
Why?
|
Optic Nerve | 1 | 2018 | 66 | 0.040 |
Why?
|
Nitric Oxide | 1 | 2004 | 884 | 0.040 |
Why?
|
Respiratory Care Units | 1 | 2017 | 2 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2022 | 551 | 0.040 |
Why?
|
Role | 1 | 2018 | 33 | 0.040 |
Why?
|
Toll-Like Receptor 2 | 1 | 2018 | 131 | 0.040 |
Why?
|
Healthy Volunteers | 1 | 2018 | 209 | 0.040 |
Why?
|
Retinal Ganglion Cells | 1 | 2018 | 92 | 0.040 |
Why?
|
Heterozygote | 1 | 2018 | 270 | 0.040 |
Why?
|
Societies | 1 | 2017 | 42 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2013 | 1711 | 0.040 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 313 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2005 | 1814 | 0.040 |
Why?
|
Neuroprotective Agents | 1 | 2018 | 110 | 0.040 |
Why?
|
Japan | 1 | 2017 | 108 | 0.040 |
Why?
|
Crystallography, X-Ray | 1 | 2019 | 430 | 0.040 |
Why?
|
Protein Structure, Tertiary | 2 | 2014 | 832 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2020 | 395 | 0.040 |
Why?
|
Cricetinae | 2 | 2011 | 269 | 0.040 |
Why?
|
Phosphotyrosine | 2 | 2009 | 47 | 0.040 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2018 | 99 | 0.040 |
Why?
|
Tetraspanin 30 | 2 | 2010 | 9 | 0.040 |
Why?
|
Cattle | 1 | 2020 | 994 | 0.040 |
Why?
|
Genomics | 1 | 2022 | 714 | 0.040 |
Why?
|
Liver | 1 | 2005 | 1827 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2019 | 9692 | 0.040 |
Why?
|
Bronchodilator Agents | 1 | 2019 | 257 | 0.040 |
Why?
|
Platelet Membrane Glycoproteins | 2 | 2010 | 43 | 0.040 |
Why?
|
Postmenopause | 1 | 2019 | 307 | 0.040 |
Why?
|
Microglia | 1 | 2018 | 214 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2002 | 1260 | 0.040 |
Why?
|
Neutrophil Infiltration | 2 | 2009 | 100 | 0.040 |
Why?
|
Protein Conformation | 1 | 2019 | 851 | 0.030 |
Why?
|
Complement Activation | 1 | 2018 | 349 | 0.030 |
Why?
|
RNA | 1 | 2001 | 854 | 0.030 |
Why?
|
Microscopy, Electron | 2 | 2006 | 418 | 0.030 |
Why?
|
Chemokines, CXC | 2 | 2006 | 66 | 0.030 |
Why?
|
Acute Disease | 1 | 2018 | 984 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2008 | 232 | 0.030 |
Why?
|
Chemokine CXCL12 | 2 | 2006 | 81 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2004 | 1562 | 0.030 |
Why?
|
Neuronal Apoptosis-Inhibitory Protein | 1 | 2014 | 1 | 0.030 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2014 | 17 | 0.030 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 6 | 0.030 |
Why?
|
Hydroxyproline | 1 | 2014 | 23 | 0.030 |
Why?
|
Tacrolimus Binding Proteins | 1 | 2014 | 16 | 0.030 |
Why?
|
Nod1 Signaling Adaptor Protein | 1 | 2014 | 12 | 0.030 |
Why?
|
Nod2 Signaling Adaptor Protein | 1 | 2014 | 30 | 0.030 |
Why?
|
Survival Analysis | 1 | 2018 | 1325 | 0.030 |
Why?
|
Exercise | 1 | 2005 | 1743 | 0.030 |
Why?
|
fas Receptor | 1 | 2014 | 95 | 0.030 |
Why?
|
Alveolar Bone Loss | 1 | 2013 | 10 | 0.030 |
Why?
|
Practice Patterns, Physicians' | 1 | 2002 | 1267 | 0.030 |
Why?
|
Enzyme Induction | 1 | 2013 | 94 | 0.030 |
Why?
|
Brain | 1 | 2005 | 2540 | 0.030 |
Why?
|
Remission Induction | 1 | 2014 | 246 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2004 | 4734 | 0.030 |
Why?
|
Calcium Channels | 2 | 2004 | 154 | 0.030 |
Why?
|
NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2014 | 152 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 1855 | 0.030 |
Why?
|
Calcium-Binding Proteins | 1 | 2014 | 222 | 0.030 |
Why?
|
Talin | 1 | 2012 | 7 | 0.030 |
Why?
|
Integrin beta1 | 1 | 2012 | 20 | 0.030 |
Why?
|
Pandemics | 1 | 2021 | 1401 | 0.030 |
Why?
|
Adolescent | 3 | 2009 | 18948 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2012 | 1093 | 0.030 |
Why?
|
ADAM17 Protein | 1 | 2012 | 33 | 0.030 |
Why?
|
Vimentin | 1 | 2012 | 62 | 0.030 |
Why?
|
ADAM Proteins | 1 | 2012 | 60 | 0.030 |
Why?
|
Base Sequence | 2 | 2006 | 2186 | 0.030 |
Why?
|
Pinocytosis | 1 | 2011 | 11 | 0.030 |
Why?
|
Oncogenes | 1 | 2012 | 118 | 0.030 |
Why?
|
Epidermal Growth Factor | 1 | 2012 | 173 | 0.030 |
Why?
|
Erythrocytes | 2 | 2009 | 636 | 0.030 |
Why?
|
Chemokine CXCL1 | 1 | 2011 | 69 | 0.030 |
Why?
|
Mesoderm | 1 | 2012 | 148 | 0.030 |
Why?
|
Cricetulus | 1 | 2011 | 100 | 0.030 |
Why?
|
CHO Cells | 1 | 2011 | 145 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2011 | 72 | 0.020 |
Why?
|
Observation | 1 | 2011 | 55 | 0.020 |
Why?
|
In Vitro Techniques | 2 | 2003 | 1130 | 0.020 |
Why?
|
Trauma Severity Indices | 1 | 2011 | 128 | 0.020 |
Why?
|
Oxygen | 2 | 2006 | 887 | 0.020 |
Why?
|
Antigens, Differentiation | 1 | 2010 | 82 | 0.020 |
Why?
|
Guanosine Triphosphate | 1 | 2010 | 92 | 0.020 |
Why?
|
Adenoma | 1 | 2012 | 196 | 0.020 |
Why?
|
Stem Cells | 1 | 2015 | 576 | 0.020 |
Why?
|
Risk Factors | 1 | 2004 | 9381 | 0.020 |
Why?
|
Endotoxins | 1 | 2011 | 234 | 0.020 |
Why?
|
Recovery of Function | 1 | 2014 | 610 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2014 | 740 | 0.020 |
Why?
|
Alanine-tRNA Ligase | 1 | 2009 | 3 | 0.020 |
Why?
|
Threonine-tRNA Ligase | 1 | 2009 | 3 | 0.020 |
Why?
|
Stress Fibers | 1 | 2009 | 18 | 0.020 |
Why?
|
Amiloride | 1 | 2009 | 26 | 0.020 |
Why?
|
Mammary Glands, Animal | 1 | 2010 | 123 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2010 | 551 | 0.020 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2009 | 80 | 0.020 |
Why?
|
Virulence Factors | 1 | 2010 | 143 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2012 | 415 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 839 | 0.020 |
Why?
|
Granulocytes | 1 | 2008 | 79 | 0.020 |
Why?
|
Syndrome | 1 | 2009 | 363 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2008 | 287 | 0.020 |
Why?
|
Receptors, CCR7 | 1 | 2006 | 25 | 0.020 |
Why?
|
Mice, Inbred A | 1 | 2006 | 45 | 0.020 |
Why?
|
Receptors, Chemokine | 1 | 2006 | 46 | 0.020 |
Why?
|
Receptors, CCR5 | 1 | 2006 | 55 | 0.020 |
Why?
|
Thymus Gland | 1 | 2008 | 308 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2012 | 1183 | 0.020 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2006 | 45 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2006 | 256 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2011 | 690 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2006 | 270 | 0.020 |
Why?
|
Colforsin | 1 | 2005 | 56 | 0.020 |
Why?
|
Medication Adherence | 1 | 2011 | 575 | 0.020 |
Why?
|
Hypoglossal Nerve | 1 | 2005 | 20 | 0.020 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2005 | 114 | 0.020 |
Why?
|
Spleen | 1 | 2008 | 543 | 0.020 |
Why?
|
Young Adult | 2 | 2013 | 11094 | 0.020 |
Why?
|
Interferons | 1 | 2006 | 154 | 0.020 |
Why?
|
Sex Factors | 1 | 2011 | 1860 | 0.020 |
Why?
|
Oligonucleotides, Antisense | 1 | 2005 | 102 | 0.020 |
Why?
|
Antibodies | 1 | 2008 | 400 | 0.020 |
Why?
|
Stem Cell Transplantation | 1 | 2006 | 155 | 0.020 |
Why?
|
Species Specificity | 1 | 2006 | 578 | 0.020 |
Why?
|
Calnexin | 1 | 2004 | 3 | 0.020 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 44 | 0.020 |
Why?
|
Macrocyclic Compounds | 1 | 2004 | 9 | 0.020 |
Why?
|
E-Selectin | 1 | 2005 | 53 | 0.020 |
Why?
|
Polylysine | 1 | 2004 | 19 | 0.020 |
Why?
|
Ionomycin | 1 | 2004 | 27 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2008 | 466 | 0.020 |
Why?
|
Oxazoles | 1 | 2004 | 31 | 0.020 |
Why?
|
N-Ethylmaleimide-Sensitive Proteins | 1 | 2004 | 5 | 0.020 |
Why?
|
Colorado | 1 | 2015 | 4325 | 0.020 |
Why?
|
Phospholipases A2 | 1 | 2004 | 77 | 0.020 |
Why?
|
Chelating Agents | 1 | 2005 | 75 | 0.020 |
Why?
|
Mitochondrial Membranes | 1 | 2005 | 38 | 0.020 |
Why?
|
Leukotriene B4 | 1 | 2004 | 56 | 0.020 |
Why?
|
Qa-SNARE Proteins | 1 | 2004 | 14 | 0.020 |
Why?
|
Inositol Phosphates | 1 | 2004 | 28 | 0.020 |
Why?
|
Protein Phosphatase 2 | 1 | 2004 | 42 | 0.020 |
Why?
|
Chemotactic Factors | 1 | 2004 | 51 | 0.020 |
Why?
|
Group IV Phospholipases A2 | 1 | 2004 | 45 | 0.020 |
Why?
|
Health Surveys | 1 | 2006 | 468 | 0.020 |
Why?
|
Intracellular Membranes | 1 | 2004 | 78 | 0.020 |
Why?
|
Pyrrolidines | 1 | 2004 | 57 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2004 | 139 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2004 | 170 | 0.020 |
Why?
|
Arachidonic Acid | 1 | 2004 | 121 | 0.020 |
Why?
|
Molecular Motor Proteins | 1 | 2004 | 34 | 0.020 |
Why?
|
Child | 1 | 2004 | 19561 | 0.020 |
Why?
|
Microspheres | 1 | 2004 | 132 | 0.010 |
Why?
|
Osteonectin | 1 | 2003 | 2 | 0.010 |
Why?
|
Antigens, Surface | 1 | 2004 | 166 | 0.010 |
Why?
|
Tenascin | 1 | 2003 | 13 | 0.010 |
Why?
|
Vesicular Transport Proteins | 1 | 2004 | 84 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2006 | 1245 | 0.010 |
Why?
|
Ascitic Fluid | 1 | 2003 | 15 | 0.010 |
Why?
|
Serotonin | 1 | 2005 | 311 | 0.010 |
Why?
|
Complement Hemolytic Activity Assay | 1 | 2003 | 1 | 0.010 |
Why?
|
Mesocricetus | 1 | 2003 | 33 | 0.010 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2003 | 17 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 2003 | 87 | 0.010 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2003 | 36 | 0.010 |
Why?
|
bcl-X Protein | 1 | 2003 | 44 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 2003 | 141 | 0.010 |
Why?
|
Cytoprotection | 1 | 2003 | 58 | 0.010 |
Why?
|
Complement Inactivator Proteins | 1 | 2003 | 39 | 0.010 |
Why?
|
Body Weight | 1 | 2008 | 958 | 0.010 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2005 | 207 | 0.010 |
Why?
|
Heme Oxygenase-1 | 1 | 2003 | 52 | 0.010 |
Why?
|
Leukocytes | 1 | 2004 | 295 | 0.010 |
Why?
|
Cell Count | 1 | 2003 | 319 | 0.010 |
Why?
|
Clone Cells | 1 | 2003 | 255 | 0.010 |
Why?
|
Peritonitis | 1 | 2003 | 78 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2010 | 2599 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2004 | 547 | 0.010 |
Why?
|
beta-N-Acetylhexosaminidases | 1 | 2002 | 11 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 2005 | 456 | 0.010 |
Why?
|
Superoxides | 1 | 2003 | 225 | 0.010 |
Why?
|
Chemokine CCL5 | 1 | 2002 | 50 | 0.010 |
Why?
|
Tissue Engineering | 1 | 2006 | 366 | 0.010 |
Why?
|
Oxidants | 1 | 2003 | 126 | 0.010 |
Why?
|
Swine | 1 | 2005 | 777 | 0.010 |
Why?
|
Aging | 1 | 2012 | 1694 | 0.010 |
Why?
|
Plasmids | 1 | 2003 | 358 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2008 | 936 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 2004 | 279 | 0.010 |
Why?
|
Erythropoietin | 1 | 2002 | 82 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2009 | 3296 | 0.010 |
Why?
|
Hydrogen Peroxide | 1 | 2003 | 299 | 0.010 |
Why?
|
Complement System Proteins | 1 | 2004 | 296 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2008 | 1805 | 0.010 |
Why?
|
Graft Survival | 1 | 2003 | 500 | 0.010 |
Why?
|
Dexamethasone | 1 | 2002 | 323 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2004 | 1981 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2005 | 783 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2003 | 687 | 0.010 |
Why?
|
Phenotype | 1 | 2006 | 3070 | 0.010 |
Why?
|
Myocardium | 1 | 2003 | 982 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2006 | 4768 | 0.010 |
Why?
|
Heart Transplantation | 1 | 2003 | 674 | 0.010 |
Why?
|